LBRX
#2304
LB Pharmaceuticals Inc - Common Stock
35.3 4 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.64%
Variación mensual
-21.38%
Variación en los últimos 6 meses
+38.97%
Cambio anual
+121.43%
Cierres anteriores
35.9 3
Open
36.1 0
Mínimo
35.0 2
Máximo
36.1 0
Financials
- Market Capitalization 1.14 B
- Employee 27
- Founded 2015
- CEO N/A
- Website www.lbpharma.us
- Headquarter Delaware, United States
- FIGI BBG00XNP5MQ4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.11
Relación precio/flujo de caja
77.13
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2280 |  REPL Replimune Group, Inc. - Common Stock | 12.50 USD | -4.36% | -5.73% | -3.62% | +178.40% | 1.18 B USD | ||
| 2295 |  VOR Vor Biopharma Inc. - Common Stock | 19.78 USD | -0.10% | +6.75% | -11.66% | +50.99% | 1.17 B USD | ||
| 2305 |  TYRA Tyra Biosciences, Inc. - Common Stock | 19.18 USD | -2.14% | -6.94% | -18.73% | +33.75% | 1.14 B USD | ||
| 2309 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.40 USD | +0.40% | +4.25% | -23.95% | +20.50% | 1.15 B USD |